Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Anticonvulsants Market Size Growth Rate by Type (2019-2025) 1.3.2 Epilepsy 1.3.3 Fibromyalgia 1.3.4 Migraine 1.3.5 Neuropathic pain 1.3.6 Bipolar disorder 1.3.7 Anxiety 1.3.8 Borderline personality disorder 1.4 Market Segment by Application 1.4.1 Global Anticonvulsants Market Share by Application (2019-2025) 1.4.2 Hospital 1.4.3 Clinic 1.4.4 Home Care 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Anticonvulsants Market Size 2.1.1 Global Anticonvulsants Revenue 2014-2025 2.1.2 Global Anticonvulsants Sales 2014-2025 2.2 Anticonvulsants Growth Rate by Regions 2.2.1 Global Anticonvulsants Sales by Regions 2014-2019 2.2.2 Global Anticonvulsants Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Anticonvulsants Sales by Manufacturers 3.1.1 Anticonvulsants Sales by Manufacturers 2014-2019 3.1.2 Anticonvulsants Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Anticonvulsants Revenue by Manufacturers (2014-2019) 3.2.2 Anticonvulsants Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Anticonvulsants Market Concentration Ratio (CR5 and HHI) 3.3 Anticonvulsants Price by Manufacturers 3.4 Key Manufacturers Anticonvulsants Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Anticonvulsants Market 3.6 Key Manufacturers Anticonvulsants Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Epilepsy Sales and Revenue (2014-2019) 4.1.2 Fibromyalgia Sales and Revenue (2014-2019) 4.1.3 Migraine Sales and Revenue (2014-2019) 4.1.4 Neuropathic pain Sales and Revenue (2014-2019) 4.1.5 Bipolar disorder Sales and Revenue (2014-2019) 4.1.6 Anxiety Sales and Revenue (2014-2019) 4.1.7 Borderline personality disorder Sales and Revenue (2014-2019) 4.2 Global Anticonvulsants Sales Market Share by Type 4.3 Global Anticonvulsants Revenue Market Share by Type 4.4 Anticonvulsants Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Anticonvulsants Sales by Application 6 United States 6.1 United States Anticonvulsants Breakdown Data by Company 6.2 United States Anticonvulsants Breakdown Data by Type 6.3 United States Anticonvulsants Breakdown Data by Application 7 European Union 7.1 European Union Anticonvulsants Breakdown Data by Company 7.2 European Union Anticonvulsants Breakdown Data by Type 7.3 European Union Anticonvulsants Breakdown Data by Application 8 China 8.1 China Anticonvulsants Breakdown Data by Company 8.2 China Anticonvulsants Breakdown Data by Type 8.3 China Anticonvulsants Breakdown Data by Application 9 Rest of World 9.1 Rest of World Anticonvulsants Breakdown Data by Company 9.2 Rest of World Anticonvulsants Breakdown Data by Type 9.3 Rest of World Anticonvulsants Breakdown Data by Application 9.4 Rest of World Anticonvulsants Breakdown Data by Countries 9.4.1 Rest of World Anticonvulsants Sales by Countries 9.4.2 Rest of World Anticonvulsants Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 Johnson & Johnson (J&J) 10.1.1 Johnson & Johnson (J&J) Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Anticonvulsants 10.1.4 Anticonvulsants Product Introduction 10.1.5 Johnson & Johnson (J&J) Recent Development 10.2 Novartis AG 10.2.1 Novartis AG Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Anticonvulsants 10.2.4 Anticonvulsants Product Introduction 10.2.5 Novartis AG Recent Development 10.3 UCB Group 10.3.1 UCB Group Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Anticonvulsants 10.3.4 Anticonvulsants Product Introduction 10.3.5 UCB Group Recent Development 10.4 GlaxoSmithKline plc. 10.4.1 GlaxoSmithKline plc. Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Anticonvulsants 10.4.4 Anticonvulsants Product Introduction 10.4.5 GlaxoSmithKline plc. Recent Development 10.5 Pfizer Inc. 10.5.1 Pfizer Inc. Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Anticonvulsants 10.5.4 Anticonvulsants Product Introduction 10.5.5 Pfizer Inc. Recent Development 10.6 Abbott Laboratories 10.6.1 Abbott Laboratories Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Anticonvulsants 10.6.4 Anticonvulsants Product Introduction 10.6.5 Abbott Laboratories Recent Development 10.7 Cephalon Inc. 10.7.1 Cephalon Inc. Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Anticonvulsants 10.7.4 Anticonvulsants Product Introduction 10.7.5 Cephalon Inc. Recent Development 10.8 Shire plc. 10.8.1 Shire plc. Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Anticonvulsants 10.8.4 Anticonvulsants Product Introduction 10.8.5 Shire plc. Recent Development 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Anticonvulsants Sales Channels 11.2.2 Anticonvulsants Distributors 11.3 Anticonvulsants Customers 12 Market Forecast 12.1 Global Anticonvulsants Sales and Revenue Forecast 2019-2025 12.2 Global Anticonvulsants Sales Forecast by Type 12.3 Global Anticonvulsants Sales Forecast by Application 12.4 Anticonvulsants Forecast by Regions 12.4.1 Global Anticonvulsants Sales Forecast by Regions 2019-2025 12.4.2 Global Anticonvulsants Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables and Figures Figure Anticonvulsants Product Picture Table Anticonvulsants Key Market Segments Table Major Manufacturers Anticonvulsants Covered in This Report Table Global Anticonvulsants Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$) Figure Global Anticonvulsants Sales Market Shar by Type 2014-2025 Figure Epilepsy Figures Table Major Manufacturers of Epilepsy Figure Fibromyalgia Figures Table Major Manufacturers of Fibromyalgia Figure Migraine Figures Table Major Manufacturers of Migraine Figure Neuropathic pain Figures Table Major Manufacturers of Neuropathic pain Figure Bipolar disorder Figures Table Major Manufacturers of Bipolar disorder Figure Anxiety Figures Table Major Manufacturers of Anxiety Figure Borderline personality disorder Figures Table Major Manufacturers of Borderline personality disorder Table Global Anticonvulsants Market Share by Application 2019-2025 (K Units) Figure Hospital Use Case Figure Clinic Use Case Figure Home Care Use Case Figure Anticonvulsants Report Years Considered Figure Global Anticonvulsants Market Size 2014-2025 (Million US$) Figure Global Anticonvulsants Sales 2014-2019 (K Units) Table Global Anticonvulsants Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Anticonvulsants Sales by Regions 2014-2019 (K Units) Table Global Anticonvulsants Sales Market Share by Regions 2014-2019 Figure Global Anticonvulsants Sales Market Share by Regions 2014-2019 Figure Global Anticonvulsants Sales Market Share by Regions in 2019 Table Global Anticonvulsants Revenue by Regions 2014-2019 (Million US$) Table Global Anticonvulsants Revenue Market Share by Regions 2014-2019 Figure Global Anticonvulsants Revenue Market Share by Regions 2014-2019 Figure Global Anticonvulsants Revenue Market Share by Regions in 2019 Table Market Top Trends Table Global Anticonvulsants Sales by Manufacturers (2014-2019) (K Units) Table Global Anticonvulsants Sales Share by Manufacturers (2014-2019) Figure Global Anticonvulsants Sales Share by Manufacturers in 2019 Table Anticonvulsants Revenue by Manufacturers (2014-2019) (Million USD) Table Anticonvulsants Revenue Share by Manufacturers (2014-2019) Figure Anticonvulsants Value Share by Manufacturers in 2019 Table Global Anticonvulsants Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Anticonvulsants Price (2014-2019) (USD/Unit) Table Key Manufacturers Anticonvulsants Plants/Factories Distribution Table Key Manufacturers Anticonvulsants Area Served Table Date of Key Manufacturers Enter into Anticonvulsants Market Table Key Manufacturers Anticonvulsants Product Type Table Mergers & Acquisitions, Expansion Plans Table Global Epilepsy Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Fibromyalgia Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Migraine Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Neuropathic pain Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Bipolar disorder Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Anxiety Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Borderline personality disorder Sales and Revenue (2014-2019) (K Units) & (Million US$) Table Global Anticonvulsants Sales by Type (2014-2019) (K Units) Table Global Anticonvulsants Sales Share by Type (2014-2019) Figure Global Anticonvulsants Sales Market Share by Type (2014-2019) Figure Global Anticonvulsants Sales Market Share by Type in 2018 Table Global Anticonvulsants Revenue by Type (2014-2019) (Million US$) Table Global Anticonvulsants Revenue Share by Type (2014-2019) Figure Global Anticonvulsants Revenue Market Share by Type (2014-2019) Figure Global Anticonvulsants Revenue Market Share by Type in 2018 Table Anticonvulsants Price by Type 2014-2019 (USD/Unit) Table Global Anticonvulsants Sales by Application (2014-2019) (K Units) Table Global Anticonvulsants Sales Share by Application (2014-2019) Figure Global Sales Anticonvulsants Market Share by Application (2014-2019) Figure Global Sales Anticonvulsants Market Share by Application (2014-2019) Figure United States Anticonvulsants Sales Growth Rate 2014-2019 (K Units) Figure United States Anticonvulsants Revenue Growth Rate 2014-2019 (Million US$) Table United States Anticonvulsants Sales by Company (2014-2019) (K Units) Table United States Anticonvulsants Sales Market Share by Company (2014-2019) Figure United States Anticonvulsants Sales Market Share by Company in 2019 Table United States Anticonvulsants Sales by Type (2014-2019) (K Units) Table United States Anticonvulsants Sales Market Share by Type (2014-2019) Figure United States Anticonvulsants Market Share by Type in 2019 Table United States Anticonvulsants Sales by Application (2014-2019) (K Units) Table United States Anticonvulsants Sales Market Share by Application (2014-2019) Figure United States Anticonvulsants Market Share by Application in 2019 Figure European Union Anticonvulsants Sales Growth Rate 2014-2019 (K Units) Figure European Union Anticonvulsants Revenue Growth Rate 2014-2019 (Million US$) Table European Union Anticonvulsants Sales by Company (2014-2019) (K Units) Table European Union Anticonvulsants Sales Market Share by Company (2014-2019) Figure European Union Anticonvulsants Sales Market Share by Company in 2019 Table European Union Anticonvulsants Sales by Type (2014-2019) (K Units) Table European Union Anticonvulsants Sales Market Share by Type (2014-2019) Figure 2018 European Union Anticonvulsants Market Share by Type Table European Union Anticonvulsants Sales by Application (2014-2019) (K Units) Table European Union Anticonvulsants Sales Market Share by Application (2014-2019) Figure 2018 European Union Anticonvulsants Market Share by Application Figure China Anticonvulsants Sales Growth Rate 2014-2019 (K Units) Figure China Anticonvulsants Revenue Growth Rate 2014-2019 (Million US$) Table China Anticonvulsants Sales by Company (2014-2019) (K Units) Table China Anticonvulsants Sales Market Share by Company (2014-2019) Figure China Anticonvulsants Sales Market Share by Company in 2019 Table China Anticonvulsants Sales by Type (2014-2019) (K Units) Table China Anticonvulsants Sales Market Share by Type (2014-2019) Figure China Anticonvulsants Market Share by Type in 2019 Table China Anticonvulsants Sales by Application (2014-2019) (K Units) Table China Anticonvulsants Sales Market Share by Application (2014-2019) Figure China Anticonvulsants Market Share by Application in 2019 Figure Rest of World Anticonvulsants Sales Growth Rate 2014-2019 (K Units) Figure Rest of World Anticonvulsants Revenue Growth Rate 2014-2019 (Million US$) Table Rest of World Anticonvulsants Sales by Company (2014-2019) (K Units) Table Rest of World Anticonvulsants Sales Market Share by Company (2014-2019) Figure Rest of World Anticonvulsants Sales Market Share by Company in 2019 Table Rest of World Anticonvulsants Sales by Type (2014-2019) (K Units) Table Rest of World Anticonvulsants Sales Market Share by Type (2014-2019) Figure Rest of World Anticonvulsants Market Share by Type in 2019 Table Rest of World Anticonvulsants Sales by Application (2014-2019) (K Units) Table Rest of World Anticonvulsants Sales Market Share by Application (2014-2019) Figure Rest of World Anticonvulsants Market Share by Application in 2019 Table Rest of World Anticonvulsants Sales by Countries (2014-2019) (K Units) Table Rest of World Anticonvulsants Sales Market Share by Countries (2014-2019) Figure Rest of World Anticonvulsants Sales Market Share by Countries in 2019 Table Rest of World Anticonvulsants Revenue by Countries (2014-2019) (Million US$) Table Rest of World Anticonvulsants Revenue Market Share by Countries (2014-2019) Figure Rest of World Anticonvulsants Revenue Market Share by Countries in 2019 Figure Japan Anticonvulsants Sales Growth Rate (2014-2019) (K Units) Figure Japan Anticonvulsants Revenue Growth Rate (2014-2019) (K Units) Figure Korea Anticonvulsants Sales Growth Rate (2014-2019) (K Units) Figure Korea Anticonvulsants Revenue Growth Rate (2014-2019) (K Units) Figure India Anticonvulsants Sales Growth Rate (2014-2019) (K Units) Figure India Anticonvulsants Revenue Growth Rate (2014-2019) (K Units) Figure Southeast Asia Anticonvulsants Sales Growth Rate (2014-2019) (K Units) Figure Southeast Asia Anticonvulsants Revenue Growth Rate (2014-2019) (K Units) Table Johnson & Johnson (J&J) Company Details Table Johnson & Johnson (J&J) Description and Business Overview Table Johnson & Johnson (J&J) Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Johnson & Johnson (J&J) Anticonvulsants Sales Growth Rate (2014-2019) Table Johnson & Johnson (J&J) Anticonvulsants Sales Market Share in Global Market Table Johnson & Johnson (J&J) Recent Development Table Novartis AG Company Details Table Novartis AG Description and Business Overview Table Novartis AG Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis AG Anticonvulsants Sales Growth Rate (2014-2019) Table Novartis AG Anticonvulsants Sales Market Share in Global Market Table Novartis AG Recent Development Table UCB Group Company Details Table UCB Group Description and Business Overview Table UCB Group Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table UCB Group Anticonvulsants Sales Growth Rate (2014-2019) Table UCB Group Anticonvulsants Sales Market Share in Global Market Table UCB Group Recent Development Table GlaxoSmithKline plc. Company Details Table GlaxoSmithKline plc. Description and Business Overview Table GlaxoSmithKline plc. Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline plc. Anticonvulsants Sales Growth Rate (2014-2019) Table GlaxoSmithKline plc. Anticonvulsants Sales Market Share in Global Market Table GlaxoSmithKline plc. Recent Development Table Pfizer Inc. Company Details Table Pfizer Inc. Description and Business Overview Table Pfizer Inc. Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Pfizer Inc. Anticonvulsants Sales Growth Rate (2014-2019) Table Pfizer Inc. Anticonvulsants Sales Market Share in Global Market Table Pfizer Inc. Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories Description and Business Overview Table Abbott Laboratories Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Abbott Laboratories Anticonvulsants Sales Growth Rate (2014-2019) Table Abbott Laboratories Anticonvulsants Sales Market Share in Global Market Table Abbott Laboratories Recent Development Table Cephalon Inc. Company Details Table Cephalon Inc. Description and Business Overview Table Cephalon Inc. Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Cephalon Inc. Anticonvulsants Sales Growth Rate (2014-2019) Table Cephalon Inc. Anticonvulsants Sales Market Share in Global Market Table Cephalon Inc. Recent Development Table Shire plc. Company Details Table Shire plc. Description and Business Overview Table Shire plc. Anticonvulsants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019) Table Shire plc. Anticonvulsants Sales Growth Rate (2014-2019) Table Shire plc. Anticonvulsants Sales Market Share in Global Market Table Shire plc. Recent Development Figure Anticonvulsants Value Chain Table Anticonvulsants Distributors List Table Anticonvulsants Customers List Table Global Anticonvulsants Sales Forecast 2019-2025 (K Units) & (Million US$) Figure Global Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure Global Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Table Global Anticonvulsants Sales Forecast by Type 2019-2025 (K Units) Figure Global Anticonvulsants Sales Forecast by Type 2019-2025 (K Units) Figure Global Anticonvulsants Sales Market Share Forecast by Type 2019-2025 Table Global Anticonvulsants Sales Forecast by Application 2019-2025 (K Units) Figure Global Anticonvulsants Sales Forecast by Application 2019-2025 (K Units) Figure Global Anticonvulsants Sales Market Share Forecast by Application 2019-2025 Table Global Anticonvulsants Sales Forecast by Regions 2019-2025 (K Units) Figure Global Anticonvulsants Sales Forecast by Regions 2019-2025 (K Units) Figure Global Anticonvulsants Sales Market Share Forecast by Regions 2019-2025 Table Global Anticonvulsants Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Anticonvulsants Revenue Forecast by Regions 2019-2025 (K Units) Figure Global Anticonvulsants Revenue Market Share Forecast by Regions 2019-2025 Figure United States Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure United States Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Figure European Union Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure European Union Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Figure China Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure China Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Figure Japan Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure Japan Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Figure Korea Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure Korea Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Figure India Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure India Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Figure Southeast Asia Anticonvulsants Sales Forecast 2019-2025 (K Units) Figure Southeast Asia Anticonvulsants Revenue Forecast 2019-2025 (Million US$) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Johnson & Johnson (J&J) Novartis AG UCB Group GlaxoSmithKline plc. Pfizer Inc. Abbott Laboratories Cephalon Inc. Shire plc.